Treatment:

More Info
Brian P. Brennan, MD, MMSc

Associate Director, Biological Psychiatry Laboratory, McLean Hospital
Medical Director, Obsessive Compulsive Disorder Institute, McLean Hospital
Assistant Professor of Psychiatry, Harvard Medical School

OCD Institute

The investigation of novel biological targets for the development of improved pharmacologic therapies for mood and anxiety disorders.

More Info
Alisa B. Busch, MD, MS

McLean Hospital Chief Medical Information Officer and Director of Clinical Performance Measurement & Health Services Research

More Info
Jeff Cottrell, PhD

Director of Translational Research, Stanley Center for Psychiatric Research, Broad Institute

Translation of research on the genetics of psychiatric disease into strategies for the development of novel, mechanism-based therapeutics.

More Info
John Denninger, MD, PhD

Director of Research, Benson-Henry Institute for Mind Body Medicine, MGH
Instructor in Psychiatry, Harvard Medical School

Benson-Henry Institute for Mind Body Medicine

Mechanisms of mind body interventions for stress-related illness; neurobiological studies in major depressive disorders

More Info
A. Eden Evins, M.D., M.P.H.

Associate Professor of Psychiatry, HMS

MGH, Director, Center for Addiction Medicine

discovery and development of novel pharmacologic and behavioral treatments for substance abuse

More Info
Marlene Freeman, MD

Director of Clinical Services, MGH Center for Women's Health
Associate Professor of Psychiatry, MGH

MGH Center for Women's Mental Health

clinical research, clinical trials, perinatal psychiatry, mood disorders in pregnancy and postpartum period, menopause, complementary and alternative treatments for depression in women

More Info
Shelly Greenfield, MD, MPH

Chief Academic Officer, McLean Hospital
Chief, Division of Women’s Mental Health, McLean Hospital
Director, Alcohol and Drug Abuse Clinical and Health Services Research Program, McLean Hospital
Professor of Psychiatry, Harvard Medical School

Alcohol and Drug Abuse Treatment Program

Development of new treatments for patients with substance use disorders and innovating the integration of delivery of mental health and substance abuse treatment services into diverse settings

More Info
Kevin P. Hill, MD, MHS

Director, Substance Abuse Consultation Service, Division of Alcohol and Drug Abuse, McLean Hospital
Assistant Professor of Psychiatry, Harvard Medical School

Alcohol and Drug Abuse Treatment Program

Substance use disorders (especially cannabis, alcohol, and opioids), smoking cessation

More Info
John Kelly, Ph.D.

Director, Addiction Recovery Management Service (ARMS), MGH; Director, Recovery Research Institute, MGH; Associate Director, Center for Addiction Medicine, MGH; Elizabeth R. Spallin Associate Professor of Psychiatry in the Field of Addiction Medicine, HMS

Addiction Recovery Management Services

experimental and naturalistic studies that develop and test new treatments for individuals with substance use disorders

More Info
Sara Lazar, PhD

Assistant Professor of Psychology, MGH
Assistant Professor of Psychiatry, Harvard Medical School

Meditation Research

neural mechanisms underlying efficacious mind-body techniques such as mindfulness meditation and yoga

More Info
John Matthews, MD, MSc

Medical Director, Bulfinch Program, MGH
Director, Inpatient Research and Training, MGH
Assistant Professor of Psychiatry, Harvard Medical School

Depression Clinical & Research Program

cognitive deficits in patients with depression, treatments for bipolar disorder, treatments for psychotic depression

More Info
George Papakostas, MD

Director, Treatment-Resistant Depression Studies, Depression & Clinical Research Program, MGH
Associate Professor of Psychiatry, Harvard Medical School

Depression Clinical & Research Program

treatment-resistant depression

More Info
Diego Pizzagalli, PhD

Director, Center for Depression, Anxiety and Stress Research, McLean Hospital
Director, McLean Imaging Center
Director, Laboratory for Translational and Affective Neuroscience
Professor of Psychiatry, Harvard Medical School

Laboratory for Affective and Translational Neuroscience

Behavioral, electrophysiological, and neuroimaging approaches to investigate cognitive and affective dysfunction in depression and anxiety disorders; improve our understanding the pathophysiology of these disorders; and develop biomarkers of treatment response.

More Info
Scott L. Rauch, MD

President, Psychiatrist-in-Chief, and Rose-Marie and Eijk van Otterloo Chair of Psychiatry, McLean Hospital
Professor of Psychiatry, Harvard Medical School
Chair of Partners Psychiatry and Mental Health, Partners Healthcare

brain basis of psychiatric disorders, as well as normal cognitive and affective functions. Translation of findings into improved care for individuals with neuropsychiatric disease.

More Info
Jack Rogers, PhD

Director, Neurochemistry Laboratory, MGH; Associate Professor of Psychiatry and Neuroscience, HMS

MassGeneral Neurochemistry Laboratory

therapeutic intervention against neurodegenerative diseases; molecular biology approaches, including the use of RNA targeting techniques

More Info
Jerrold F. Rosenbaum, MD

Chief of Psychiatry, MGH
President & Executive Director, Mood and Anxiety Disorders Institute (MADI), MGH
Stanley Cobb Professor of Psychiatry, Harvard Medical School

Mood and Anxiety Disorders Institute (MADI)

treatment resistant depression, anxiety disorders, genetic and temperamental links to anxiety and mood disorders

More Info
Frank I. Tarazi, MBBS, PhD, MBA

Director, Psychiatric Neuroscience Laboratory, McLean Hospital
Associate Professor of Psychiatry, Harvard Medical School

Psychiatric Neuroscience Laboratory

More Info
Roger Weiss, MD

Chief, Division of Alcohol and Drug Abuse, McLean Hospital
Director, Alcohol and Drug Abuse Clinical Research Program, McLean Hospital
Professor of Psychiatry, Harvard Medical School

Alcohol and Drug Abuse Treatment Program

Alcohol and drug abuse research

More Info
Mary Zanarini, EdD

Program Director, Laboratory for the Study of Adult Development, McLean Hospital
Professor of Psychology, Harvard Medical School

McLean Center for the Treatment of Borderline Personality Disorder

Etiology, phenomenology, co-occurring disorders, treatment response, and long-term course of borderline personality disorder.a